1. Home
  2. CTKB vs TMCI Comparison

CTKB vs TMCI Comparison

Compare CTKB & TMCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTKB
  • TMCI
  • Stock Information
  • Founded
  • CTKB 1990
  • TMCI 2014
  • Country
  • CTKB United States
  • TMCI United States
  • Employees
  • CTKB N/A
  • TMCI N/A
  • Industry
  • CTKB Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • TMCI Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • CTKB Health Care
  • TMCI Health Care
  • Exchange
  • CTKB Nasdaq
  • TMCI Nasdaq
  • Market Cap
  • CTKB 433.8M
  • TMCI 401.8M
  • IPO Year
  • CTKB 2021
  • TMCI 2021
  • Fundamental
  • Price
  • CTKB $5.58
  • TMCI $2.75
  • Analyst Decision
  • CTKB Hold
  • TMCI Hold
  • Analyst Count
  • CTKB 4
  • TMCI 6
  • Target Price
  • CTKB $5.88
  • TMCI $7.07
  • AVG Volume (30 Days)
  • CTKB 1.6M
  • TMCI 1.0M
  • Earning Date
  • CTKB 11-05-2025
  • TMCI 11-06-2025
  • Dividend Yield
  • CTKB N/A
  • TMCI N/A
  • EPS Growth
  • CTKB N/A
  • TMCI N/A
  • EPS
  • CTKB N/A
  • TMCI N/A
  • Revenue
  • CTKB $196,828,000.00
  • TMCI $218,879,000.00
  • Revenue This Year
  • CTKB N/A
  • TMCI $10.63
  • Revenue Next Year
  • CTKB $7.25
  • TMCI $9.43
  • P/E Ratio
  • CTKB N/A
  • TMCI N/A
  • Revenue Growth
  • CTKB N/A
  • TMCI 7.90
  • 52 Week Low
  • CTKB $2.37
  • TMCI $2.60
  • 52 Week High
  • CTKB $7.30
  • TMCI $10.79
  • Technical
  • Relative Strength Index (RSI)
  • CTKB 71.13
  • TMCI 16.66
  • Support Level
  • CTKB $5.10
  • TMCI $3.40
  • Resistance Level
  • CTKB $6.18
  • TMCI $2.87
  • Average True Range (ATR)
  • CTKB 0.43
  • TMCI 0.40
  • MACD
  • CTKB 0.09
  • TMCI -0.19
  • Stochastic Oscillator
  • CTKB 75.21
  • TMCI 5.33

About CTKB Cytek Biosciences Inc.

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.

About TMCI Treace Medical Concepts Inc.

Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers and hospitals.

Share on Social Networks: